ArticleJournal of gynecologic oncology2026

Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trial.

Shuhua Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.